Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹10.59
Market cap: ₹237.5 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-292.9 Cr
P/E (TTM): -1.0×Sector 47.3×
Promoter holding: 51.84%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 3 Other Announcement 2 Merger & Restructuring 2 Annual General Meeting 2 Financial Results 1 Business Update 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Jul 2026 11:00 IST BSE

Business Update

Nectar Lifesciences Business Update

Nectar LifeSciences Ltd filed its shareholding pattern as per Regulation 31(1)(b), detailing promoter and public holdings as of June 30, 2026. No monetary transaction disclosed.

Read the filing ↗